Federica O’Brien

Federica O’Brien has been a member of our Board since November 2019. Ms. O’Brien is President of CFO’Brien Consulting, LLC, which she founded in January 2018, providing strategic, operational and financial consulting, and flexible time Chief Financial Officer services primarily for biotech companies. Previously she served as Chief Financial Officer of Complexa Inc., a biopharmaceutical company, from May 2015 to December 2017 and as Chief Financial Officer of Cerecor Inc., a biopharmaceutical company, from April 2013 to May 2015. Prior to that, Ms. O’Brien held senior financial and operational management positions at Cervilenz, Inc, a privately held medical device company, Cardiokine Inc., a privately held biotechnology company, Barrier Therapeutics, Inc., during and subsequent to the biotechnology company’s initial public offering, and at Infonautics, Inc., then a publicly held technology company.
Ms. O’Brien currently serves on the board of directors for MacroGenics, Inc., a biopharmaceutical company, where she also chairs the Audit Committee. She began her career at public accounting firms, most recently as an Audit Manager for Coopers & Lybrand, now part of PwC. Ms. O’Brien received her B.A. in Accounting from Rutgers University and is a Certified Public Accountant — Inactive in the State of New Jersey, retired after 38 years.